UK-based medical technology company, Moletest (Scotland) Ltd, is offering primary care professionals the opportunity to reduce the number of dermatology referrals to secondary care with nomela, a screening test for skin lesions suspected of melanoma.
WHY IT MATTERS
GPs and other primary care professionals will be able to use a nomela iPad to take images of the suspect skin lesion, which are...
